A Phase 4 interventional study of Greater Occipital Nerve Block with dexamethasone and lidocaine and Greater Occipital Nerve Block with 0.9% saline in Chronic Migraine and Headache, sponsored by Pain Medicine Department. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-01-12.
Sponsored by Pain Medicine Department · Phase 4, Interventional, and Treatment
The study was carried to determine the analgesic efficacy of greater occipital nerve block in patients of migraine. It was a randomised controlled which took place from april 2022 - october 2022. Fifty patients suffering from migraine were included in the study. Patients in Group G were given greater occipital nerve block (GONB) with lignocaine and dexamethasone under ultrasound guidance while those in Group S were given saline 0.9% as placebo. Pain score using Numeric Rating Scale and number of headache days was assessed at four,eight and twelve weeks after the procedure as a primary outcome. Total headache days were recorded as a secondary outcome.
1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.
This study's enrollment of 50 is below the median of 80 across 1,175 interventional studies indexed under Migraine Disorders.
Browse Migraine Disorders studies →Pain Medicine Department is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Greater occipital nerve block (GONB) under ultrasound guidance with lidocaine and dexamethasone on the side of headache
Drug: Greater Occipital Nerve Block with dexamethasone and lidocaine · Drug: Greater Occipital Nerve Block with 0.9% saline
Greater occipital nerve block (GONB) under ultrasound guidance on the side of headache with 0.9% Saline (Placebo)
Drug: Greater Occipital Nerve Block with dexamethasone and lidocaine · Drug: Greater Occipital Nerve Block with 0.9% saline
Ultrasound guided Greater occipital nerve block on the side of headache
Also known as: GONB with dexamethasone and lidocaine
Ultrasound guided Greater occipital nerve block on the side of headache
Also known as: GONB with 0.9% saline
Analgesic efficacy
Change in Pain score assessed on Numeric Rating Scale (NRS) which ranges from 0 to 10. 0 is no pain and 10 is maximum pain.
Time frame: 12 weeks
Headache days
Number of headache days over the course of study period.
Time frame: 12 weeks
This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pain Medicine Department